tiprankstipranks
Trending News
More News >
Pro Medicus Limited (AU:PME)
ASX:PME
Australian Market
Advertisement

Pro Medicus Limited (PME) Financial Statements

Compare
165 Followers

Pro Medicus Limited Financial Overview

Pro Medicus Limited's market cap is currently $31.60B. The company's EPS TTM is AU$0.607; its P/E ratio is 275.15; and it has a dividend yield of 0.15%. Pro Medicus Limited is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is AU$0.68. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 212.91MAU$ 161.43MAU$ 124.90MAU$ 93.46MAU$ 67.88M
Gross ProfitAU$ 212.60MAU$ 122.24MAU$ 92.36MAU$ 92.94MAU$ 46.66M
Operating IncomeAU$ 157.61MAU$ 112.18MAU$ 83.87MAU$ 62.39MAU$ 42.38M
EBITDAAU$ 164.85MAU$ 120.69MAU$ 91.69MAU$ 69.64MAU$ 49.53M
Net IncomeAU$ 115.22MAU$ 82.79MAU$ 60.65MAU$ 44.44MAU$ 30.85M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 209.19MAU$ 154.89MAU$ 121.50MAU$ 90.55MAU$ 61.82M
Total AssetsAU$ 338.70MAU$ 257.43MAU$ 202.13MAU$ 157.05MAU$ 125.57M
Total DebtAU$ 2.25MAU$ 2.07MAU$ 1.85MAU$ 2.28MAU$ 2.62M
Net DebtAU$ -172.28MAU$ -57.99MAU$ -89.40MAU$ -61.38MAU$ -39.42M
Total LiabilitiesAU$ 81.74MAU$ 69.70MAU$ 63.36MAU$ 55.32MAU$ 43.89M
Stockholders' EquityAU$ 256.96MAU$ 187.73MAU$ 138.78MAU$ 101.73MAU$ 81.68M
Cash Flow
Free Cash FlowAU$ 103.95MAU$ 80.08MAU$ 58.33MAU$ 53.20MAU$ 31.33M
Operating Cash FlowAU$ 111.33MAU$ 86.78MAU$ 64.77MAU$ 62.23MAU$ 39.02M
Investing Cash FlowAU$ -6.58MAU$ -78.07MAU$ -9.79MAU$ -17.56MAU$ -27.40M
Financing Cash FlowAU$ -57.62MAU$ -39.84MAU$ -27.53MAU$ -23.31MAU$ -14.05M
Currency in AUD

Pro Medicus Limited Earnings and Revenue History

Pro Medicus Limited Debt to Assets

Pro Medicus Limited Cash Flow

Pro Medicus Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis